The Pediatric Nephrology Fellowship Program hosted in the Division of Pediatric Nephrology was initiated in 1965 by Drs. Alfred Michael and Robert Vernier.
Our training program is a three-year program accredited by the ACGME. It has historically been a major contributor to the current national and international pool of Pediatric Nephrology faculty. Since the formal organization of this training program in 1965, over 120 candidates have completed training. About three-quarters of those who have completed one or more years of training have occupied full-time positions in academic departments. Approximately 20 graduates have directed academic Pediatric Nephrology divisions.
Program graduates provide high quality teaching and patient care, and demonstrate a continued dedication to improved understanding of disease through research based on the philosophy acquired during their training. A remarkable number of our graduates have successfully competed for NIH funding and other independent research support.
The primary objective of this training program is to prepare physicians who have completed clinical training in Pediatrics for academic, research-oriented faculty positions in Pediatric Nephrology. Candidates for this program have expressed an intense desire to pursue academic careers devoted to enhancing the understanding of renal disorders and the care of children with kidney disease through innovative basic research, clinical investigation, teaching and advocacy, and a commitment to devote a minimum of three years of post-residency training to achieving these goals.
We appreciate your interest in the University of Minnesota's Pediatric Nephrology Fellowship Program and look forward to reviewing your application. Our program participates in the National Resident Match Program (NRMP) and will accept applications only through the Electronic Residency Application Service (ERAS). Please contact the Program Director, Dr. Sara Kizilbash (email@example.com), if you have any questions not answered here on the webpage.
- Applicants must have completed an ACGME-accredited residency program, or its equivalent, by the fellowship start date.
- Fellows are selected primarily on the basis of likely success in an academic career in Pediatric Nephrology.
- We accept only applicants who are U.S. citizens or permanent residents (green card holders), or those who have a J-1 Visa.
- The following documents are required:
- 3 letters of recommendation from members of your faculty
- Personal statement
- USMLE transcript
- ECFMG certificate (if applicable)
- Medical School Diploma
The University of Minnesota demonstrates a commitment to leveraging the transformative power of equity and diversity to advance excellence in teaching, learning and community engagement. Applications from individuals who self-identify as members of underrepresented groups are particularly welcome.
First year: In the first year, trainees perform clinical service in all divisional inpatient and outpatient activities under the direction of supervising attending faculty. Fellows will rotate through at least 6 months of inpatient experience including the care of children with all conditions managed by pediatric nephrologists including acute and chronic dialysis and kidney transplantation. Inpatient experience occurs at both at a freestanding academic tertiary hospital and at a community children's hospital in order to provide a wide breadth of consultative experience. Fellows will participate in an outpatient continuity clinic weekly where they will develop their own panel of patients to follow throughout their training, including longitudinal care of chronic dialysis patients. Training to perform percutaneous biopsies will be provided. Didactic teaching will occur weekly both in the Division of Pediatric Nephrology and in conjunction with the adult nephrology program. Additional time will be spent during the first year exploring research opportunities and developing a research plan for the remainder of the fellowship
Second and third year: An additional 6 months of inpatient experience will be spread throughout the second and third years of fellowship to refine and enhance clinical training. The remainder of the rime during these years will be spent in research activity, either basic science or clinical research. Fellows will have the opportunity to learn every aspect of research including clinical study design, preparation of institutional review board applications, patient enrollment and/or data extraction, statistical analysis, and writing for publication. Fellows will be expected to submit and present their work at a national nephrology meeting such as the American Society of Pediatric Nephrology or American Society of Nephrology meeting. Clinical schedules can be adjusted to accommodate pursuit of a Masters in Clinical Research through the School of Public Health.
Research opportunities: Pediatric nephrology faculty at the University of Minnesota have a wide variety of research projects that fellows are welcome to participate in. Fellows ahve the opportunity to perform research utilizing the Alport Syndrome Treatments and Outcomes Registry (ASTOR), the largest registry of children and adults with Alport syndrome in the US. The University of Minnesota is a participating center in the Midwest Pediatric Nephrology Consortium (MWPNC), a collaborative nephrology research network, and fellows have the opportunity to participate in those MWPNC studies. The University of Minnesota maintains a large pediatric kidney transplant database that is available for analysis as well as access to USRDS and SRTR databases. Finally, the University of Minnesota participates in a number of multicenter studies including the CureGlomerulopathy study, a longitudinal cohort study of children and adults with glomerular disease, the Improving Renal Outcomes Collaborative (IROC), a quality improvement project for children with CKD and post kidney transplant, the Standard Care to Improve Outcomes in Pediatric Endstage Renal Disease (SCOPE) collaborative, a quality improvement project to prevent dialysis associated infections, and the PRI-VENT FSGS study, a prospective study of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-transplant. Additional research opportunities are available in collaboration with rheumatology, adult nephrology, or other divisions within the medical school depending on a fellow's interests and experience.